| ISSN |
2219-2832 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Review |
| Article Title |
Comprehensive treatment for the peritoneal metastasis from gastric cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yutaka Yonemura, Emel Canbay, Yoshio Endou, Haruaki Ishibashi, Akiyosi Mizumoto, Yan Li, Yang Liu, Kazuyoshi Takeshita, Masumi Ichinose, Nobuyuki Takao, Takuya Saitou, Kousuke Noguchi, Masamitu Hirano, Oliver Glehen, Bjorn Brűcher and Paul H Sugarbaker |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yutaka Yonemura, MD, PhD, Director, NPO to Support Peritoneal Surface Malignancy Treatment, Oosaka, Kishiwada 596-0032, Japan. y.yonemura@coda.ocn.ne.jp |
| Key Words |
Gastric cancer; Hyperthermic intraoperative intraperitoneal chemotherapy; Peritoneal metastasis; Peritonectomy |
| Core Tip |
This article reviews the results of the comprehensive treatment for peritoneal metastasis from gastric cancer, and verifies the effects of cytoreductive surgery and perioperative chemotherapy, including neoadjuvant chemotherapy (NAC), and hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC). Multivariate analyses revealed that the completeness of cytoreduction, peritoneal cancer index less than the threshold levels after NAC, cytologic status, pathologic response after NAC are the independent prognostic factors. Patients satisfying these factors are recommended to undergo D2-gastrectomy combined with complete removal of PC and HIPEC. |
| Publish Date |
2015-07-08 08:39 |
| Citation |
Yonemura Y, Canbay E, Endou Y, Ishibashi H, Mizumoto A, Li Y, Liu Y, Takeshita K, Ichinose M, Takao N, Saitou T, Noguchi K, Hirano M, Glehen O, Brűcher B, Sugarbaker PH. Comprehensive treatment for the peritoneal metastasis from gastric cancer. World J Surg Proced 2015; 5(2): 187-197 |
| URL |
http://www.wjgnet.com/2219-2832/full/v5/i2/187.htm |
| DOI |
http://dx.doi.org/10.5412/wjsp.v5.i2.187 |
